|
Real-time Estimate
Cboe BZX
15:50:00 2026-11-03 EST
|
5-day change | 1st Jan Change | ||
| 3.745 USD | +3.74% |
|
-6.05% | -36.46% |
| 10-19 | Clene Inc. Submits New Drug Application to Fda for Cnm-Au8 for the Treatment of Als | CI |
| 09-15 | Top Midday Gainers | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 51.31M | - | ||||
| 62.23B | |||||
| 54.92B | |||||
| 55.26B | |||||
| 42.59B | |||||
| 41.08B |
- Stock Market
- Stocks
- CLNN Stock
- Charts Clene Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
